CVS Health’s State Street SPDR S&P 500 ETF Trust SPY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-87,578
Closed -$57M 27
2026
Q1
$57M Sell
87,578
-66,313
-43% -$45.1M 26.83% 1
2025
Q4
$105M Hold
153,891
77.55% 1
2025
Q3
$103M Sell
153,891
-154,000
-50% -$98.7M 99.64% 1
2025
Q2
$190M Hold
307,891
99.79% 1
2025
Q1
$172M Sell
307,891
-90,000
-23% -$52.9M 99.74% 1
2024
Q4
$233M Buy
397,891
+110,000
+38% +$64.8M 99.77% 1
2024
Q3
$165M Hold
287,891
71.75% 1
2024
Q2
$157M Hold
287,891
72.25% 1
2024
Q1
$151M Hold
287,891
71.11% 1
2023
Q4
$137M Buy
287,891
+63,295
+28% +$28.2M 70.63% 1
2023
Q3
$96M Hold
224,596
51.34% 1
2023
Q2
$99.6M Buy
224,596
+76,496
+52% +$32.1M 51.49% 1
2023
Q1
$60.6M Buy
+148,100
New +$59.1M 36.1% 1

Other funds holding SPY

CVS Health's SPY Position: Q2 2026 in Review

CVS Health sold out of State Street SPDR S&P 500 ETF Trust (SPY) in Q2 2026, closing a stake of 87,578 shares — an estimated $57M sold.

CVS Health first reported a position in SPY in Q1 2023 and held it in 13 quarters. The position peaked at $233M in Q4 2024. 4,617 funds tracked by Wall St. Rank hold SPY as of Q2 2026.

  • CVS Health reported no remaining State Street SPDR S&P 500 ETF Trust position as of Q2 2026 after selling out during the quarter.
  • CVS Health sold 87,578 State Street SPDR S&P 500 ETF Trust shares in Q2 2026, an estimated $57M.
  • CVS Health first reported a position in State Street SPDR S&P 500 ETF Trust in Q1 2023 and held it in 13 quarters.
  • CVS Health's State Street SPDR S&P 500 ETF Trust position peaked at $233M in Q4 2024.
  • 4,617 funds tracked by Wall St. Rank held State Street SPDR S&P 500 ETF Trust as of Q2 2026.

Based on CVS Health's 13F filing for Q2 2026, filed 6 Aug 2026.